[Ocular manifestation in LCAT deficiency--a clinicopathological correlation].
BACKGROUND
Bilateral stromal corneal opacifications are important to detect potentially associated systemic diseases. Differential diagnosis includes, besides inflammatory diseases mucopolysaccharidoses, HDL deficiencies (LCAT deficiency, Tangier disease and fish eye disease), Schnyder's crystalline corneal dystrophy, lipid keratopathy, cystinosis, gout and mucolipidoses.


METHODS
The cornea of a 60-year old male patient, 180 cm height, showed milky hazy diffuse stromal inclusions with a prominent lipoid arc (VA O. D. 20/30 and O. S. 20/40, contre-jour VA less than 20/150). Ten years earlier, lattice corneal dystrophy was diagnosed. The cornea was thickened (0.61 mm). Except for the cornea, the anterior and posterior segments of the eye were unremarkable. Serum HDL concentration was decreased pathologically (7 mg/dl), although the LCAT activity was combined with apo-AI deficiency. Due to membrane instability, the erythrocytes showed target cell configuration. Penetrating excimer-laser keratoplasty was performed O. S. The epithelial wound closed only on the 32nd postoperative day. Histologically, the corneal stroma showed multiple vacuoles and amyloid deposits. Genetic analysis revealed two mutations in chromosome 16.


CONCLUSIONS
To our knowledge, this is the second description in the literature of a patient with LCAT deficiency and secondary amyloidosis of the cornea. Additionally, LCAT deficiency is associated with anaemia and proteinuria. After a penetrating keratoplasty, prolonged wound healing is possible. Because of the bilateral corneal clouding, the ophthalmologist may help to identify patients with LCAT deficiency. Thus, it is possible to start antiarteriosclerotic therapy.
Viestenz
Arne
A
Augenklinik mit Poliklinik, Friedrich-Alexander-Universität Erlangen-Nuremberg, Erlangen. Arne.Viestenz@t-online.de
Seitz
Berthold
B
D028226:Amyloidosis, Familial / Q000175:diagnosis / Q000235:genetics / Q000473:pathology / Q000601:surgery; D016632:Apolipoprotein A-I / Q000172:deficiency / Q000235:genetics; D001112:Arcus Senilis / Q000175:diagnosis / Q000473:pathology; D002885:Chromosomes, Human, Pair 16; D003317:Corneal Dystrophies, Hereditary / Q000175:diagnosis / Q000235:genetics / Q000473:pathology / Q000601:surgery; D003318:Corneal Opacity / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology / Q000601:surgery; D003319:Corneal Stroma / Q000473:pathology; D004252:DNA Mutational Analysis; D003937:Diagnosis, Differential; D006801:Humans; D015948:Keratoplasty, Penetrating; D053685:Laser Therapy; D007863:Lecithin Cholesterol Acyltransferase Deficiency / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009887:Ophthalmoscopy; D007862:Phosphatidylcholine-Sterol O-Acyltransferase / Q000235:genetics
D016632:Apolipoprotein A-I; D007862:Phosphatidylcholine-Sterol O-Acyltransferase